Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.31 |
| ▸ | NCF1 | P14598 | 2/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4349511 | 0.96 | NQO1 (0.31) | NQO1 | |
| SCHEMBL2349220 | 0.92 | CYP2A6 (0.44) | CYP1A2CYP2A6 | |
| SCHEMBL29895562 | 0.92 | CYP2A6 (0.44) | CYP1A2CYP2A6 | |
| SCHEMBL14267378 | 0.90 | CYP2A6 (0.38) | CYP1A2CYP2A6 | |
| SCHEMBL4585250 | 0.90 | CYP2A6 (0.38) | CYP1A2CYP2A6 | |
| SCHEMBL14267373 | 0.90 | CYP2A6 (0.38) | CYP1A2CYP2A6 | |
| SCHEMBL4584709 | 0.90 | CYP2A6 (0.38) | CYP1A2CYP2A6 | |
| SCHEMBL14437796 | 0.87 | — | — | |
| SCHEMBL14437797 | 0.87 | — | — | |
| SCHEMBL4585529 | 0.87 | CYP1A2 (0.45) | CYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3430100-A1 | POLYSILOXANE FORMULATIONS AND COATINGS FOR OPTOELECTRONIC APPLICATIONS, METHODS OF PRODUCTION, AND USES THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2019-01-23 | — | — | EP | claimed |
| WO-2017160509-A1 | POLYSILOXANE FORMULATIONS AND COATINGS FOR OPTOELECTRONIC APPLICATIONS, METHODS OF PRODUCTION, AND USES THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2017-09-21 | — | — | WO | claimed |
| US-20170260419-A1 | POLYSILOXANE FORMULATIONS AND COATINGS FOR OPTOELECTRONIC APPLICATIONS, METHODS OF PRODUCTION, AND USES THEREOF | HONEYWELL INTERNATIONAL INC. | 2017-09-14 | — | — | US | claimed |
| US-20150011787-A1 | PROCESS FOR PREPARING ORGANIC-INORGANIC HYBRID SILICATES AND METAL-SILICATES WITH AN ORDERED STRUCTURE AND NEW HYBRID SILICATES AND METAL-SILICATES | ENI S.P.A. (IT) | 2015-01-08 | — | — | US | claimed |
| EP-2797841-A1 | PROCESS FOR PREPARING ORGANIC-INORGANIC HYBRID SILICATES AND METAL-SILICATES WITH AN ORDERED STRUCTURE AND NEW HYBRID SILICATES AND METAL-SILICATES | ENI S.p.A. (IT) | 2014-11-05 | — | — | EP | claimed |
| WO-2013098261-A1 | PROCESS FOR PREPARING ORGANIC-INORGANIC HYBRID SILICATES AND METAL-SILICATES WITH AN ORDERED STRUCTURE AND NEW HYBRID SILICATES AND METAL-SILICATES | ENI S.P.A. (IT) | 2013-07-04 | — | — | WO | claimed |
| US-20250257239-A1 | POLYSILOXANE COMPOSITIONS FOR OPTOELECTRONIC DEVICE APPLICATIONS INVOLVING MOISTURE SENSITIVE LAYERS | SOLSTICE ADVANCED MATERIALS US, INC. | 2025-08-14 | — | — | US | disclosed |
| US-11015082-B2 | Crack-resistant polysiloxane dielectric planarizing compositions, methods and films | HONEYWELL INTERNATIONAL INC. (US) | 2021-05-25 | — | — | US | disclosed |
| EP-3728500-A1 | CRACK-RESISTANT POLYSILOXANE DIELECTRIC PLANARIZING COMPOSITIONS, METHODS AND FILMS | Honeywell International Inc. (US) | 2020-10-28 | — | — | EP | disclosed |
| US-20190185709-A1 | CRACK-RESISTANT POLYSILOXANE DIELECTRIC PLANARIZING COMPOSITIONS, METHODS AND FILMS | SOLSTICE ADVANCED MATERIALS US, INC. | 2019-06-20 | — | — | US | disclosed |
| EP-3430100-A1 | POLYSILOXANE FORMULATIONS AND COATINGS FOR OPTOELECTRONIC APPLICATIONS, METHODS OF PRODUCTION, AND USES THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2019-01-23 | — | — | EP | disclosed |
| EP-3430100-A1 | POLYSILOXANE FORMULATIONS AND COATINGS FOR OPTOELECTRONIC APPLICATIONS, METHODS OF PRODUCTION, AND USES THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2019-01-23 | — | — | EP | disclosed |
| WO-2017160509-A1 | POLYSILOXANE FORMULATIONS AND COATINGS FOR OPTOELECTRONIC APPLICATIONS, METHODS OF PRODUCTION, AND USES THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2017-09-21 | — | — | WO | disclosed |
| WO-2017160509-A1 | POLYSILOXANE FORMULATIONS AND COATINGS FOR OPTOELECTRONIC APPLICATIONS, METHODS OF PRODUCTION, AND USES THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2017-09-21 | — | — | WO | disclosed |
| US-20170260419-A1 | POLYSILOXANE FORMULATIONS AND COATINGS FOR OPTOELECTRONIC APPLICATIONS, METHODS OF PRODUCTION, AND USES THEREOF | HONEYWELL INTERNATIONAL INC. | 2017-09-14 | — | — | US | disclosed |
| US-20150011787-A1 | PROCESS FOR PREPARING ORGANIC-INORGANIC HYBRID SILICATES AND METAL-SILICATES WITH AN ORDERED STRUCTURE AND NEW HYBRID SILICATES AND METAL-SILICATES | ENI S.P.A. (IT) | 2015-01-08 | — | — | US | disclosed |
| EP-2797841-A1 | PROCESS FOR PREPARING ORGANIC-INORGANIC HYBRID SILICATES AND METAL-SILICATES WITH AN ORDERED STRUCTURE AND NEW HYBRID SILICATES AND METAL-SILICATES | ENI S.p.A. (IT) | 2014-11-05 | — | — | EP | disclosed |
| WO-2013098261-A1 | PROCESS FOR PREPARING ORGANIC-INORGANIC HYBRID SILICATES AND METAL-SILICATES WITH AN ORDERED STRUCTURE AND NEW HYBRID SILICATES AND METAL-SILICATES | ENI S.P.A. (IT) | 2013-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011787-A1 | PROCESS FOR PREPARING ORGANIC-INORGANIC HYBRID SILICATES AND METAL-SILICATES WITH AN ORDERED STRUCTURE AND NEW HYBRID SILICATES AND METAL-SILICATES | DIS3, EDF1, CA4 | NQO1 4139/4885CYP1A2 2102/4885CYP2A6 3230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.